Related Experiment Videos

Taxoid compounds in breast cancer: current status and future prospects

¹Jules Bordet Institute, Brussels, Belgium.

Cancer Treatment and Research

|January 1, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

ESMO-Magnitude of Clinical Benefit Scale version 1.1.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answers.

ESMO open·2016

The current use and attitudes towards tumor genome sequencing in breast cancer.

Scientific reports·2016

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

Long-term toxic effects of adjuvant chemotherapy in breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2011

See all related articles